|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibson MK and Forastiere AA:
Multidisciplinary approaches in the management of advanced head and
neck tumors: State of the art. Curr Opin Oncol. 16:220–224. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Albers AE, Chen C, Köberle B, Qian X,
Klussmann JP, Wollenberg B and Kaufmann AM: Stem cells in squamous
head and neck cancer. Crit Rev Oncol Hematol. 81:224–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bustin M, Lehn DA and Landsman D:
Structural features of the HMG chromosomal proteins and their
genes. Biochim Biophys Acta. 1049:231–243. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang WK, Lu QH, Zhang JN, Wang B, Liu XJ,
An FS, Qin WD, Chen XY, Dong WQ, Zhang C, et al: HMGB1 mediates
hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1
signalling pathway. J Cell Mol Med. 18:2311–2320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Stolz DB, Sappington PL, Macias CA,
Killeen ME, Tenhunen JJ, Delude RL and Fink MP: HMGB1 is secreted
by immunostimulated enterocytes and contributes to cytomix-induced
hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol.
290:C990–C999. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Vishnubhakat JM, Bloom O, Zhang M,
Ombrellino M, Sama A and Tracey KJ: Proinflammatory cytokines
(tumor necrosis factor and interleukin 1) stimulate release of high
mobility group protein-1 by pituicytes. Surgery. 126:389–392. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim NG, Choi YR, Baek MJ, Kim YH, Kang H,
Kim NK, Min JS and Kim H: Frameshift mutations at coding
mononucleotide repeats of the hRAD50 gene in gastrointestinal
carcinomas with microsatellite instability. Cancer Res. 61:36–38.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang S, Xu L, Yang T and Wang F:
High-mobility group box-1 and its role in angiogenesis. J Leukoc
Biol. 95:563–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang R, Tang D, Schapiro NE, Loux T,
Livesey KM, Billiar TR, Wang H, Van Houten B, Lotze MT and Zeh HJ:
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor
growth by regulating mitochondrial bioenergetics. Oncogene.
33:567–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu Y, Chen Y, Fu X, Zhang L, Tian J and
Hao Q: HMGB1 promotes lymphangiogenesis of human lymphatic
endothelial cells in vitro. Med Oncol. 29:358–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sims GP, Rowe DC, Rietdijk ST, Herbst R
and Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev
Immunol. 28:367–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi J, Lee MK, Oh KH, Kim YS, Choi HY,
Baek SK, Jung KY, Woo JS, Lee SH and Kwon SY: Interaction effect
between the receptor for advanced glycation end products (RAGE) and
high-mobility group box-1 (HMGB-1) for the migration of a squamous
cell carcinoma cell line. Tumori. 97:196–202. 2011.PubMed/NCBI
|
|
18
|
Mittal D, Saccheri F, Venereau E, Pusterla
T, Bianchi ME and Rescigno M: TLR4-mediated skin carcinogenesis is
dependent on immune and radioresistant cells. EMBO J. 29:2242–2252.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu LX, Yan L, Yang W, Wu FQ, Ling Y, Chen
SZ, Tang L, Tan YX, Cao D, Wu MC, et al: Platelets promote tumour
metastasis via interaction between TLR4 and tumour cell-released
high-mobility group box 1 protein. Nat Commun. 5:52562014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wild CA, Brandau S, Lotfi R, Mattheis S,
Gu X, Lang S and Bergmann C: HMGB1 is overexpressed in tumor cells
and promotes activity of regulatory T cells in patients with head
and neck cancer. Oral Oncol. 48:409–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu G, Li Y, Liu Z, Wang M, Ge J and Bai
X: Clinical value of serum HMGB1 in diagnosis and prognosis of
laryngeal squamous cell carcinoma. Med Oncol. 31:3162014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Xie C, Zhang X, Huang D, Zhou X,
Tan P, Qi L, Hu G, Tian Y and Qiu Y: Elevated expression of HMGB1
in squamous-cell carcinoma of the head and neck and its clinical
significance. Eur J Cancer. 46:3007–3015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PloS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao T, Kaufmann AM, Qian X, Sangvatanakul
V, Chen C, Kube T, Zhang G and Albers AE: Susceptibility to
cytotoxic T cell lysis of cancer stem cells derived from cervical
and head and neck tumor cell lines. J Cancer Res Clin Oncol.
139:159–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qian X, Wagner S, Ma C, Coordes A, Gekeler
J, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: Prognostic
significance of ALDH1A1-positive cancer stem cells in patients with
locally advanced, metastasized head and neck squamous cell
carcinoma. J Cancer Res Clin Oncol. 140:1151–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian X, Wagner S, Ma C, Klussmann JP,
Hummel M, Kaufmann AM and Albers AE: ALDH1-positive cancer
stem-like cells are enriched in nodal metastases of oropharyngeal
squamous cell carcinoma independent of HPV status. Oncol Rep.
29:1777–1784. 2013.PubMed/NCBI
|
|
27
|
Hanakawa H, Orita Y, Sato Y, Takeuchi M,
Takao S, Ohno K, Kohno T, Iwaki N, Marunaka H, Tamamura R, et al:
Does HMGB1 predict occult neck lymph node metastasis in early
tongue carcinoma? A case-control study of 26 patients. J Laryngol
Otol. 128:926–931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cardesa A and Slootweg PJ: Pathology of
the Head and Neck. 1st. Springer-Verlag; Heidelberg: pp. 142006
|
|
29
|
Rainsbury JW, Ahmed W, Williams HK,
Roberts S, Paleri V and Mehanna H: Prognostic biomarkers of
survival in oropharyngeal squamous cell carcinoma: Systematic
review and meta-analysis. Head Neck. 35:1048–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zuo Z, Che X, Wang Y, Li B, Li J, Dai W,
Lin CP and Huang C: High mobility group Box-1 inhibits cancer cell
motility and metastasis by suppressing activation of transcription
factor CREB and nWASP expression. Oncotarget. 5:7458–7470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiao Y, Wang HC and Fan SJ: Growth
suppression and radiosensitivity increase by HMGB1 in breast
cancer. Acta Pharmacol Sin. 28:1957–1967. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou C and Sun B: The prognostic role of
the cancer stem cell marker aldehyde dehydrogenase 1 in head and
neck squamous cell carcinomas: A meta-analysis. Oral Oncol.
50:1144–1148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qian X, Ma C, Nie X, Lu J, Lenarz M,
Kaufmann AM and Albers AE: Biology and immunology of cancer stem
(−like) cells in head and neck cancer. Crit Rev Oncol Hematol.
95:337–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen M, Liu Y, Varley P, Chang Y, He XX,
Huang H, Tang D, Lotze MT, Lin J and Tsung A: High-mobility group
box 1 promotes hepatocellular carcinoma progression through
miR-21-mediated matrix metalloproteinase activity. Cancer Res.
75:1645–1656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Z, Li S, Kaufmann AM and Albers AE:
miR-21 increases the programmed cell death 4 gene-regulated cell
proliferation in head and neck squamous carcinoma cell lines. Oncol
Rep. 32:2283–2289. 2014.PubMed/NCBI
|
|
36
|
Hammarstedt L, Lindquist D, Dahlstrand H,
Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W,
Dalianis T and Munck-Wikland E: Human papillomavirus as a risk
factor for the increase in incidence of tonsillar cancer. Int J
Cancer. 119:2620–2623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tinhofer I, Jöhrens K, Keilholz U,
Kaufmann A, Lehmann A, Weichert W, Stenzinger A, Stromberger C,
Klinghammer K, Becker ET, et al: Contribution of human papilloma
virus to the incidence of squamous cell carcinoma of the head and
neck in a European population with high smoking prevalence. Eur J
Cancer. 51:514–521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
